-
Gefitinib, sold
under the
brand name Iressa, is a
medication used for
certain breast, lung and
other cancers.
Gefitinib is an EGFR inhibitor, like erlotinib...
- the U.S. Food and Drug
Administration (FDA)
approved the
quinazoline gefitinib. The drug,
produced by AstraZeneca, is an
inhibitor of the
protein kinase...
- this case,
Gefitinib is the
inhibitor of
tyrosine kinase.
Incorrect tyrosine kinase function can lead to non-small cell lung cancer.
Gefitinib is a tyrosine...
-
Irinotecan Topotecan Etoposide Teniposide Tafluposide Bortezomib Erlotinib Gefitinib Imatinib Vemurafenib Vismodegib Azacitidine Azathioprine Capecitabine...
- for
bronchorrhea vary
depending on the
inciting cause; they include:
gefitinib -
epidermal growth factor receptor tyrosine kinase inhibitor indomethacin...
-
first generation tyrosine-kinase
inhibitors (TKIs) like
erlotinib or
gefitinib, but also
against less
common mutations which are
resistant to
these drugs...
-
Methylphenidate and dextroamphetamine-induced
peripheral vasculopathy Gefitinib Obstruction of capillaries:
Cryoglobulinaemia –
proteins in the blood...
-
imatinib may be
effective in
treatment of
dermatofibrosarcoma protuberans.
Gefitinib (Iressa, also
known as ZD1839),
targets the
epidermal growth factor receptor...
-
therapeutics directed against EGFR (called "EGFR inhibitors", EGFRi),
including gefitinib, erlotinib, afatinib,
brigatinib and
icotinib for lung cancer, and cetuximab...
- lung
cancer (NSCLC), EGFR-specific
tyrosine kinase inhibitors such as
gefitinib have
shown limited therapeutic success. This
resistance is
proposed to...
